Oryon Cell Therapies
PrivateLast Round
Series A
Mar 23, 2026
Total Funding Raised
$21M
Company Overview
Oryon Cell Therapies is a biotechnology company that develops autologous cell therapies for neurodegenerative disorders, with an initial focus on Parkinson's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oryon Cell Therapies Comps
Public and private peers based on sector, stage, and business model.
Oryon Cell Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 23, 2026 |
Oryon Cell Therapies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Byers Capital | Series A |
| Neuro.VC | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
$21M round completed.
Oryon Cell Therapies Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oryon Cell Therapies's valuation, stock price, and market status.
